Budiodarone
Atrial Fibrillation
Phase 2Active
Key Facts
About XYRA
XYRA pairs a fast‑acting anti‑arrhythmic with wearable monitoring to transform atrial fibrillation care.
View full company profileTherapeutic Areas
Other Atrial Fibrillation Drugs
| Drug | Company | Phase |
|---|---|---|
| Non-viral gene therapy for Atrial Fibrillation | Inomagen Therapeutics | Pre-clinical |
| AP31969 | Acesion Pharma | Phase 2 |
| OMT-28 | OMEICOS Therapeutics | Phase 2 |
| Echomplish AF Ablation System | Healium Medical | Preclinical |
| FARAPULSE PFA System | Boston Scientific | FDA Approved |